Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. Centre Léon Bérard, Lyon, France



Survival: 9.6 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: France
   
City/State/Province: Lyon
   
Hospital: Centre Léon Bérard
   
Journal: Link
   
Date: 3/2011

Description:
Patients:
This study involved 56 men with metastatic castration-resistant prostate cancer. The median patient age was 67.7 years.

Treatment:
Patients in this study were treated with the chemotherapy agents etoposide and carboplatin.

Toxicities:
One treatment-related death due to febrile neutropenia was reported. Grade 3-4 toxicities included neutropenia (65.5% of patients), thrombocytopenia (32.7%), and anemia (27.3%).

Results:
The median progression-free survival was 2.9 months and the median overall survival was 9.6 months.

Correspondence: Dr. A. Flechon; email: flechon@lyon.fnclcc.fr

E-mail to a Friend Email Physician More Information